Potassium Carbonate → 3-[5-(6-Chloropurin-9-yl)pentyloxy]benzamide
反応式
Br[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][O:7][C:8]1[CH:9]=[C:10]([CH:14]=[CH:15][CH:16]=1)[C:11]([NH2:13])=[O:12].[Cl:17][C:18]1[N:26]=[CH:25][N:24]=[C:23]2[C:19]=1[NH:20][CH:21]=[N:22]2.C(=O)([O-])[O-].[K+].[K+]>CN(C=O)C>[Cl:17][C:18]1[N:26]=[CH:25][N:24]=[C:23]2[C:19]=1[N:20]=[CH:21][N:22]2[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][O:7][C:8]1[CH:9]=[C:10]([CH:14]=[CH:15][CH:16]=1)[C:11]([NH2:13])=[O:12]参加物
5
実験手順
A solution of 3-(bromopentyloxy)benzamide (500 mg, 1.7 mmols), 6-chloropurine (270 mg, 1.7 mmols) and potassium carbonate (240 mg, 1.7 mmols) in DMF (7.5 ml) was stirred for two days at room temperature. The solvent was then removed under vacuum (0.001 mmHg) and the white solid (mixture of N7 and N9 isomers) was chromatographed (silica, 10% MeOH/CH2CI2) to give a single product (N9 isomer) as a glass. This was triturated with ether (=5 ml) to give a white solid which was recrystallised from ethyl acetate to give the product (120 mg, 0.33 mmols, 20% yield)
後処理
- customThe solvent was then removed under vacuum (0.001 mmHg)
- additionthe white solid (mixture of N7 and N9 isomers)
- customwas chromatographed (silica, 10% MeOH/CH2CI2)
- customto give a single product (N9 isomer) as a glass
- customThis was triturated with ether (=5 ml)
- customto give a white solid which
- customwas recrystallised from ethyl acetate
出典と根拠
- ORDレコード
- ord-15a0c93450dd4202869c724eba9dcd1b
- 出典データセット
- uspto-grants-2001_11
- 特許番号
- US06316455B1
反応ノート
読み込み中…